| Determining the Utility of a Behavioral Intervention in Chronic Migraine (NCT05415020) | Mayo Clinic | 2022-06-29 |
| Lacosamide Versus Propranolol in Migraine (NCT05851781) | Kafrelsheikh University | 2022-06-01 |
| The Lacosamide's Effect on Calcitonin Gene-related Peptide in Migraine Patients (NCT05632133) | Kafrelsheikh University | 2022-06-01 |
| Valproate Versus Topiramate in Migraine (NCT06248931) | Kafrelsheikh University | 2022-05-01 |
| Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use (NCT05342493) | Otsuka Pharmaceutical Co., Ltd. | 2022-04-20 |
| Potential Osteocatabolic Effect Caused by Anti-CGRP mAbs in Migraine Patients Treated With Anti-CGRP mAbs - an Observational Pilot Project With Prospectively Collected Health Related Data (NCT06035458) | Ente Ospedaliero Cantonale, Bellinzona | 2022-04-13 |
| A Pilot Clinical Trial of a New Neuromodulation Device for Acute Attacks of Migraine in Children and Adolescents (NCT05102591) | University of Calgary | 2022-02-22 |
| Dietary Advanced Glycation End Products and Migraine (NCT05747911) | Karabuk University | 2022-02-01 |
| Digital CBTI for Comorbid Insomnia in Chronic Migraine (NCT05244889) | University of Strathclyde | 2022-01-31 |
| An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients (NCT05153876) | University Hospital, Ghent | 2021-10-11 |
| Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial (NCT04936321) | Seattle Children's Hospital | 2021-10-01 |
| Fremanezumab, Migraine and Sleep (NCT04693533) | Beth Israel Deaconess Medical Center | 2021-07-29 |
| Transcutaneous Pulsed Radiofrequency in Migraine (NCT05499689) | Diskapi Teaching and Research Hospital | 2021-06-22 |
| Migraine Manager (R01) (NCT04567355) | Children's Hospital Medical Center, Cincinnati | 2021-06-10 |
| (Italian Migraine Registry, I-GRAINE-NEW) (NCT07163416) | IRCCS San Raffaele Roma | 2021-04-19 |
| Pain Resilience and Holistic Health Care of Migraine (NCT04743492) | Changhua Christian Hospital | 2021-04-16 |
| The Impact of nCoV-2019 on Children With Migraine (NCT06077006) | Bnai Zion Medical Center | 2021-04-01 |
| My Healthy Diary - An Electronic Diary for Remote Migraine Monitoring (NCT04828941) | Unidade Local de Saúde de Matosinhos, EPE | 2021-03-28 |
| Mind Body Balance for Pediatric Migraine (NCT04715685) | Children's Hospital Medical Center, Cincinnati | 2021-03-09 |
| Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old (NCT04748601) | Upsher-Smith Laboratories | 2021-02-19 |
| Comparison of Craniosacral Therapy and Myofacial Relaxation Techniques in People Diagnosed With Migraine (NCT04976725) | Alanya Alaaddin Keykubat University | 2021-02-10 |
| Temporal, Environmental, and Genetic Factors Regulating Exercise and Migraine (NCT04553445) | University of Nevada, Las Vegas | 2020-11-23 |
| Management of Migraine Using Enerumab and Traditional Therapy at the Time of COVID-19 (NCT05052008) | Fayoum University | 2020-08-15 |
| Comparison of Great Occipital Nerve and Supraorbital Nerve Blockade Methods at Treatment of Acute Migraine Attack in the Emergency Department (NCT04491474) | Dr. Lutfi Kirdar Kartal Training and Research Hospital | 2020-08-15 |
| Therapy for Migraine Prevention in Children 6-11 Years of Age (NCT04050293) | Supernus Pharmaceuticals, Inc. | 2020-07-14 |
| The Effect of Intravenous Fluid Therapy in Acute Migraine Attacks (NCT04287140) | Marmara University | 2020-04-01 |
| Mindfulness During COVID-19 (NCT04319445) | Wake Forest University Health Sciences | 2020-03-23 |
| Cognitive Function and Autonomic Regulation in Patients With Migraine (NCT04272229) | Fortaleza University | 2020-01-15 |
| HD-EEG Connectivity Changes in Migraine Patients Undergoing Treatment With Anti-CGRP mAbs (NCT06155123) | IRCCS National Neurological Institute "C. Mondino" Foundation | 2020-01-14 |
| Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Migraine (NCT04069897) | St. Olavs Hospital | 2019-10-01 |
| Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study (NCT04084314) | Novartis Pharmaceuticals | 2019-09-30 |
| Migraine Abortive Treatment (NCT05048914) | Bnai Zion Medical Center | 2019-09-03 |
| A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients (NCT03977649) | Novartis Pharmaceuticals | 2019-07-30 |
| Acupuncture as Migraine Prophylaxis in Reducing Frequency, Duration and Intensity of Migraine With Minimum Acupoint, Seen up to Eight Weeks From Baseline (NCT04509141) | Indonesia University | 2019-07-05 |
| Predicting Migraine Attacks Based on Environmental and Behavioral Changes as Detected From the Smartphone (NCT03762902) | Lifegraph Ltd. | 2019-04-30 |
| A Study of Home-Delivered Neurostimulation for Migraine (NCT03874351) | MJHS Institute for Innovation in Palliative Care | 2019-04-22 |
| Efficacy of a Novel App-based Migraine Treatment Platform - a Pilot Study (NCT04106505) | Norwegian University of Science and Technology | 2019-01-11 |
| 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine (NCT03578354) | Massachusetts Eye and Ear Infirmary | 2019-01-01 |
| Defining the Sympathetic Skin Response of Migraineurs in the Facial Area (NCT03772860) | Hillel Yaffe Medical Center | 2018-12-01 |
| Osteopathic Manipulative Treatment and Migraine Headaches (NCT04976985) | St. Luke's Hospital, Pennsylvania | 2018-10-02 |
| Mind and Body Approaches to Pain Reduction in Youth With Migraine (NCT03472092) | Children's Hospital Medical Center, Cincinnati | 2018-10-02 |
| Stroke-like Migraine Attacks After Radiation Treatment (SMART) Syndrome Language Intervention (NCT03662295) | Quality Living, Inc. | 2018-09-03 |
| Day to Day Variation of Pressure Pain Threshold and Muscle Hardness (NCT03632928) | Danish Headache Center | 2018-09-01 |
| The Relationship Between Right-to-left Shunt and Brain White Matter Lesions in Patients With Migraine (NCT03418766) | The First Hospital of Jilin University | 2018-06-15 |
| Testing myWHI: Online Self-help Programs for Headaches (NCT03504150) | IWK Health Centre | 2018-05-04 |
| "Follow the Sutures". A New Procedure for Injection of Botulinum Toxin for Chronic Migraine (NCT03543254) | Norwegian University of Science and Technology | 2018-05-01 |
| Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) (NCT03229798) | Sorrento Therapeutics, Inc. | 2018-01-17 |
| Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine (NCT03193359) | Allergan | 2018-01-15 |
| Topical Bimatoprost in the Treatment of Migraine (NCT03419715) | Manistee Partners | 2018-01-05 |
| A Study of Lasmiditan in Participants With Migraine (NCT03247790) | Eli Lilly and Company | 2017-08-16 |
| Muscle Tenderness and Hardness in Migraine Patients (NCT03626805) | Danish Headache Center | 2017-08-13 |
| BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine (NCT03193346) | Allergan | 2017-07-03 |
| Treatment of Chronic Migraine Headaches. (NCT03220113) | Corona Doctors Medical Clinics, Inc. | 2017-07-01 |
| Integrative Migraine Pain Alleviation Through Chiropractic Therapy (NCT03177616) | Harvard University Faculty of Medicine | 2017-06-07 |
| Magnesium, Partenium, Andrographis, Co-enzyme Q10 and Riboflavin (PACR) in Migraine Prophylaxis (NCT03190044) | University of Roma La Sapienza | 2017-06-06 |
| Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population (NCT03055767) | University of California, Irvine | 2017-03-01 |
| Continue or Stop Applying Wet Cupping (Al-Hijamah) in Migraine (NCT03479060) | Karabuk University | 2017-01-03 |
| A Ketogenic Diet Acts on Cortical But Not Subcortical Responsivity in Migraineurs (NCT03775252) | University of Roma La Sapienza | 2017-01-01 |
| Understanding the Pathophysiology of Migraine Pain (NCT03026101) | Montefiore Medical Center | 2017-01-01 |
| Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic Migraine (NCT02974153) | Alder Biopharmaceuticals, Inc. | 2016-11-01 |
| CBT Depression Intervention for Co-Occurring Chronic Headache (NCT02870725) | University of Georgia | 2016-11-01 |
| Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit (NCT02910921) | Second Opinion Health | 2016-11-01 |
| Intervention for Sleep and Pain in Youth (NCT03137147) | Seattle Children's Hospital | 2016-10-01 |
| Biomarker Study in Participants With Migraine (NCT02766517) | Eli Lilly and Company | 2016-09-28 |
| The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine (NCT03588364) | University of California, San Diego | 2016-09-15 |
| Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up (NCT02578719) | Bozok University | 2016-07-01 |
| Transcranial Direct Current Simulation in Chronic Migraine (NCT02817139) | Federal University of Paraíba | 2016-06-01 |
| Optimized tDCS for the Treatment of Migraine (NCT02562222) | Universidade Federal de Pernambuco | 2016-05-01 |
| Efficacy of Proprioceptive Neuromuscular Facilitation in Pain Relief (NCT02549885) | Universidade Federal de Pernambuco | 2016-04-01 |
| Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT (NCT02779959) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2016-04-01 |
| Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application (NCT02758990) | Verifomics LLC | 2016-03-01 |
| tDCS for the Treatment of Migraine (NCT02562196) | Universidade Federal de Pernambuco | 2016-03-01 |
| An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine (NCT02565186) | Eli Lilly and Company | 2015-10-07 |
| IV Haloperidol for the Treatment of Headache in the ED (NCT02747511) | Western Michigan University School of Medicine | 2015-10-01 |
| A Multicenter Assessment of ALD403 in Frequent Episodic Migraine (NCT02559895) | Alder Biopharmaceuticals, Inc. | 2015-09-01 |
| Patient Reported Outcomes in Patients With Chronic Migraine Treated With BOTOX® (NCT02502123) | Allergan | 2015-07-02 |
| Effects of the Visual Stimulation on the Motor and Visual Cortex in Migraneurs With and Without Aura (NCT02564822) | Universidade Federal de Pernambuco | 2015-07-01 |
| 1H Magnetic Resonance Spectroscopy in Migraine Patients (NCT04220606) | Leiden University Medical Center | 2015-04-01 |
| How Can we Treat Photophobia in Migraine (NCT05369910) | Medical University of Vienna | 2015-04-01 |
| Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial (NCT02314351) | Kocaeli University | 2014-12-01 |
| A Multicenter Assessment of ALD403 in Chronic Migraine (NCT02275117) | Alder Biopharmaceuticals, Inc. | 2014-10-01 |
| Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients (NCT03435185) | Dr. Lutfi Kirdar Kartal Training and Research Hospital | 2014-09-01 |
| Trial of Nortriptyline and Topiramate in the Initial Treatment of Vestibular Migraine (NCT02169830) | St. Louis University | 2014-08-22 |
| Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in Adults (NCT02191579) | Allergan | 2014-08-05 |
| Nutrition for Migraine Prevention (NCT02012790) | University of North Carolina, Chapel Hill | 2014-07-01 |
| Chronic Pain Risk Associated With Menstrual Period Pain (NCT02214550) | Endeavor Health | 2014-07-01 |
| A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic Migraine (NCT02147561) | Allergan | 2014-07-01 |
| A Study of LY2951742 in Healthy Japanese and Caucasian Participants (NCT02104765) | Eli Lilly and Company | 2014-06-01 |
| A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache (NCT01946126) | Allergan | 2014-03-01 |
| Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Child and Adolescent Patients With Migraine (NCT01942486) | University of Utah | 2014-01-01 |
| Thin Film Spectacle Coatings to Reduce Light Sensitivity and Headaches in Patients With Migraine (NCT01828684) | Bradley Katz | 2013-03-01 |
| A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine (NCT01662492) | Allergan | 2012-10-01 |
| An Observational Study of BOTOX® as Headache Prophylaxis for Chronic Migraine (NCT01686581) | Allergan | 2012-07-23 |
| Chronic Migraine Epidemiology and Outcomes Study (NCT01648530) | Allergan | 2012-07-01 |
| The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine (NCT01653522) | The Cleveland Clinic | 2012-07-01 |
| The Childhood and Adolescent Migraine Prevention Study (NCT01581281) | Children's Hospital Medical Center, Cincinnati | 2012-06-01 |
| Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea (NCT01976611) | Allergan | 2012-06-01 |
| Safety Tolerability and Pharmacokinetics of ALD403 (NCT01579383) | Alder Biopharmaceuticals, Inc. | 2012-04-01 |
| The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine (NCT01228552) | Behar, Caren, M.D. | 2011-12-01 |
| A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine (NCT01516892) | Allergan | 2011-12-01 |